Gianluca Gaidano

Gianluca Gaidano

UNVERIFIED PROFILE

Are you Gianluca Gaidano?   Register this Author

Register author
Gianluca Gaidano

Gianluca Gaidano

Publications by authors named "Gianluca Gaidano"

Are you Gianluca Gaidano?   Register this Author

100Publications

4260Reads

46Profile Views

Methods for Measuring ctDNA in Lymphomas.

Methods Mol Biol 2019 ;1881:253-265

Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-4939-8876-1_19
Publisher Site
http://dx.doi.org/10.1007/978-1-4939-8876-1_19DOI Listing
July 2019

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.

Cell 2019 Jul 4;178(3):699-713.e19. Epub 2019 Jul 4.

Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2019.06.011DOI Listing
July 2019

Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology.

Leuk Res 2019 Jun 2;81:88-94. Epub 2019 May 2.

Center for the Study of Myelofibrosis. IRCCS Policlinico S. Matteo Foundation, Pavia, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.04.016DOI Listing
June 2019

Liquid biopsy in lymphoma.

Haematologica 2019 Apr 7;104(4):648-652. Epub 2019 Mar 7.

Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.206177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442975PMC
April 2019

Reply to J. Wang et al.

J Clin Oncol 2019 Mar 12;37(9):755-757. Epub 2019 Feb 12.

David M. Kurtz, MD, PhD; Florian Scherer, MD; Michael C. Jin; Joanne Soo; Alexander F.M. Craig, MPhil; Mohammad S. Esfahani, PhD; Jacob J. Chabon, PhD; Henning Stehr, PhD; Chih Long Liu, PhD; Robert Tibshirani, PhD; Lauren S. Maeda, MD; Neel K. Gupta, MD; Michael S. Khodadoust, MD, PhD; Ranjana H. Advani, MD; and Aaron M. Newman, PhD, Stanford University, Stanford, CA; Ulrich Dührsen, MD; and Andreas Hüttmann, MD, University Hospital Essen, Essen, Germany; Michel Meignan, MD, PhD, Hôpitaux Universitaires Henri Mondor, Creteil, France; Olivier Casasnovas, MD, Centre Hospitalier Universitaire, Dijon, France; Jason R. Westin, MD, The University of Texas MD Anderson Cancer Center, Houston, TX; Mark Roschewski, MD; and Wyndham H. Wilson, MD, PhD, National Institutes of Health, Bethesda, MD; Gianluca Gaidano, MD, PhD; and Davide Rossi, MD, PhD, University of Eastern Piedmont, Novara, Italy, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland; and Maximilian Diehn, MD, PhD; and Ash A. Alizadeh, MD, PhD, Stanford University, Stanford, CA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.01907
Publisher Site
http://dx.doi.org/10.1200/JCO.18.01907DOI Listing
March 2019

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.

J Clin Oncol 2018 10 20;36(28):2845-2853. Epub 2018 Aug 20.

David M. Kurtz, Florian Scherer, Michael C. Jin, Joanne Soo, Alexander F.M. Craig, Mohammad Shahrokh Esfahani, Jacob J. Chabon, Henning Stehr, Chih Long Liu, Robert Tibshirani, Lauren S. Maeda, Neel K. Gupta, Michael S. Khodadoust, Ranjana H. Advani, Ronald Levy, Aaron M. Newman, Maximilian Diehn, and Ash A. Alizadeh, Stanford University, Stanford, CA; Florian Scherer, University Medical Center Freiburg, Freiburg; Ulrich Dührsen and Andreas Hüttmann, University Hospital Essen, Essen, Germany; Michel Meignan, Hôpitaux Universitaires Henri Mondor, Creteil; René-Olivier Casasnovas, Hôpital Le Bocage, Centre Hospitalier Universitaire, Dijon, France; Jason R. Westin, University of Texas MD Anderson Cancer Center, Houston, TX; Mark Roschewski and Wyndham H. Wilson, National Cancer Institute, National Institutes of Health, Bethesda, MD; Gianluca Gaidano and Davide Rossi, University of Eastern Piedmont, Novara, Italy; and Davide Rossi, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.5246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161832PMC
October 2018

Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study.

Leukemia 2018 08 30;32(8):1803-1807. Epub 2018 Jan 30.

Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0024-1DOI Listing
August 2018

Biology and treatment of Richter syndrome.

Blood 2018 06 24;131(25):2761-2772. Epub 2018 Apr 24.

Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-01-791376DOI Listing
June 2018

Potential of BCL2 as a target for chronic lymphocytic leukemia treatment.

Expert Rev Hematol 2018 05 29;11(5):391-402. Epub 2018 Mar 29.

a Division of Hematology, Department of Translational Medicine , University of Eastern Piedmont , Novara , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1456332DOI Listing
May 2018

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma.

J Clin Oncol 2018 03 2;36(7):689-696. Epub 2017 Nov 2.

Stefano Luminari, Angela Ferrari, and Francesco Merli, Azienda Ospedaliera Arcispedale Santa Maria Nuova-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Reggio Emilia; Stefano Luminari, Martina Manni, Alessandra Dondi, Vittoria Tarantino, Luigi Marcheselli, and Massimo Federico, University of Modena and Reggio Emilia, Modena, Italy; Annalisa Chiarenza, Azienda Ospedaliera Universitaria Policlinico-Vittorio Emanuele, University of Catania, Catania; Chiara Rusconi, Azienda Socio Sanitaria Territoriale (ASST) -Grande Ospedale Metropolitano Niguarda; Andrés J.M. Ferreri, IRCCS San Raffaele Scientific Institute, Milano; Alessandra Tucci, ASST-Spedali Civili di Brescia, Brescia; Umberto Vitolo, Città della Salute e della Scienza University and Hospital, Torino; Sofia Kovalchuk, University of Florence, Florence; Emanuele Angelucci, Ospedale Policlinico San Martino, Genova; Alessandro Pulsoni, Sapienza University of Rome, Rome; Luca Arcaini, Fondazione IRCCS Policlinico San Matteo, Pavia; Francesco Angrilli, Spirito Santo Hospital, Pescara; Gianluca Gaidano, University of Eastern Piedmont, Novara; Caterina Stelitano, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria; Giovanni Bertoldero, Ospedale di Mirano, Mirano; Nicola Cascavilla, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo; Flavia Salvi, Ospedale SS Antonio e Biagio, Alessandria; and Daniele Vallisa, Guglielmo da Saliceto Hospital, Piacenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1652DOI Listing
March 2018

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):329-337

Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2017.1.329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142556PMC
December 2017

Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia.

Curr Cancer Drug Targets 2016 ;16(8):659-668

Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Via Franco Gallini 2, Postal code 33081, Aviano (PN), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568009616666160809102219DOI Listing
October 2017

A MALT lymphoma prognostic index.

Blood 2017 09 18;130(12):1409-1417. Epub 2017 Jul 18.

Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-03-771915DOI Listing
September 2017

Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice?

Blood 2017 08 10;130(7):859-866. Epub 2017 Jul 10.

Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-03-737403DOI Listing
August 2017

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

J Clin Oncol 2017 May 28;35(14):1591-1597. Epub 2017 Mar 28.

Sophie Park, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, Université Grenoble Alpes, Grenoble; Jean-François Hamel and Sylvain Thépot, CHU d'Angers; Sylvain Thépot, Université d'Angers, Institut National de la Santé et de la Recherche Médicale, Unité 1232, and LabEx IGO, Angers; Andrea Toma, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris-Est Créteil; Rosa Sapena and Pierre Fenaux, CHU Saint Louis, AP-HP, Université Paris X; François Dreyfus, CHU Cochin, AP-HP, Université Paris V, Paris; Charikleia Kelaidi, CHU Avicenne, Avicenne; Odile Beyne-Rauzy, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Agnès Guerci-Bresler, CHU Nancy, Nancy; Dominique Bordessoule, CHU Dupuytren, Limoges; Pascale Cony-Makhoul, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy; Stéphane Cheze, CHU de Caen, Caen; Eric Wattel, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon; Christian Rose, Université Catholique de Lille, Lille; Norbert Vey, Institut Paoli-Calmettes Marseille, Marseille, France; Maria Diez Campelo, Hospital Universitario de Salamanca, Salamanca; Teresa Bernal, Hospital Central de Asturias, Oviedo; Fernando Ramos, Hospital de León, León; Marisa Calabuig, Hospital Clínico de Valencia; Guillermo F. Sanz, Hospital Universitario y Politecnico La Fe, Valencia, Spain; Valeria Santini and Alessandro Sanna, Azienda Ospedaliero Universitaria (AOU) Careggi and University of Florence, Florence; Enrico Balleari, Istituto di Ricovero e Cura a Carattere Scientifico AOU San Martino di Genova, Genova; Daniela Gioia, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria; Dario Ferrero, Università degli Studi di Torino; Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Torino; Giovanni Cametti, Ospedale Maggiore di Chieri, Chieri; Fabrizio Pane, Università Federico II, Napoli, Italy; Mikkael A. Sekeres and Jaime Fensterl, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Rami Komrokji, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David P. Steensma, Dana-Farber Cancer Institute, Boston, MA; Gail J. Roboz, Weill Medical College of Cornell University, New York, NY; Jennifer Kaivers and Ulrich Germing, University of Düsseldorf, Düsseldorf; Katharina Götze and Catharina Müller-Thomas, Universität München, München, Germany; and Ioannis Kotsianidis, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3271DOI Listing
May 2017

Diffuse large B-cell lymphoma genotyping on the liquid biopsy.

Blood 2017 04 17;129(14):1947-1957. Epub 2017 Jan 17.

Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-05-719641DOI Listing
April 2017

Common nonmutational activation in chronic lymphocytic leukemia.

Proc Natl Acad Sci U S A 2017 04 17;114(14):E2911-E2919. Epub 2017 Mar 17.

Institute for Cancer Genetics and the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1702564114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389283PMC
April 2017

Chronic lymphocytic leukaemia: a step ahead in the journey toward eradication.

Lancet Oncol 2017 02 13;18(2):163-164. Epub 2017 Jan 13.

Division of Haematology, Department of Translational Medicine, University of Eastern Piedmont and Maggiore Charity Hospital, 28100 Novara, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30017-7DOI Listing
February 2017

Regulatory agencies should engage in drug pricing.

BMJ 2016 Aug 23;354:i4524. Epub 2016 Aug 23.

Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.i4524DOI Listing
August 2016

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.

J Clin Oncol 2016 Apr 16;34(12):1376-85. Epub 2016 Feb 16.

Pier Luigi Zinzani, Alessandro Broccoli, and Lisa Argnani, Institute of Hematology L. e A. Seràgnoli, Sant'Orsola-Malpighi University Hospital, Bologna; Daniela Maria Gioia and Alessandro Levis, Fondazione Italiana Linfomi Onlus; Flavia Salvi, S.S. Antonio e Biagio Hospital, Alessandria; Antonio Castagnoli, Azienda Ospedaliera di Prato, Prato; Giovannino Ciccone and Andrea Evangelista, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino and Centro Prevenzione Oncologica Piemonte; Umberto Ricardi, University of Turin; Umberto Vitolo and Patrizia Pregno, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino; Roberto Freilone, Stabilimento Ospitaliero Ivrea, Turin; Armando Santoro, Ercole Brusamolino, and Antonella Anastasia, Istituto Clinico Humanitas; Chiara Rusconi, Azienda Ospedaliera Niguarda Cà Granda, Milan; Maurizio Bonfichi and Ercole Brusamolino, Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo di Pavia, Pavia; Giuseppe Rossi and Antonella Anastasia, Spedali Civili, Brescia; Francesco Zaja, Santa Maria della Misericordia Hospital, Udine; Vincenzo Pavone, Azienda Ospedaliera Cardinal Panico, Tricase; Alessandro Pulsoni, Sapienza University, Rome; Luigi Rigacci, Azienda Ospedaliera Careggi, Florence; Gianluca Gaidano, Amedeo Avogadro University; Gian Mauro Sacchetti, University Hospital Maggiore della Carità, Novara; Caterina Stelitano, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria; Monica Tani, Santa Maria delle Croci Hospital, Ravenna; and Eugenio Borsatti, Centro di Riferimento Oncologico, Aviano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.0699DOI Listing
April 2016

The clinical implications of gene mutations in chronic lymphocytic leukaemia.

Br J Cancer 2016 Apr 31;114(8):849-54. Epub 2016 Mar 31.

Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, 28100 Novara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.78DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984803PMC
April 2016

Richter syndrome: pathogenesis and management.

Semin Oncol 2016 Apr 15;43(2):311-9. Epub 2016 Feb 15.

Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2016.02.012DOI Listing
April 2016

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial.

J Clin Oncol 2016 Mar 25;34(9):972-9. Epub 2016 Jan 25.

Sergio Amadori, Adriano Venditti, and Maria Teresa Voso, Tor Vergata University; Luciana Annino, San Giovanni Addolorata Hospital; Paolo De Fabritiis, St Eugenio Hospital; Giuliana Alimena and Marco Mancini, Sapienza University; Francesca Paoloni, Marco Vignetti, and Paola Fazi, GIMEMA Foundation, Roma; Franco Aversa, University Hospital, Parma; Gainluca Gaidano, University of Eastern Piedmont, Novara; Maurizio Musso, La Maddalena Clinic, Palermo; Carla Mazzone, Annunziata Hospital, Cosenza; Domenico Magro, Pugliese-Ciaccio Hospital, Catanzaro; Safaa Mahmoud Ramadan, European Institute of Oncology, Milano, Italy; Stefan Suciu and Liv Meert, EORTC Headquarters, Brussels; Dominik Selleslag, AZ St Jan, Brugge; Anne Hagemeijer, KULeuven, Leuven; Frédéric Baron, Centre Hospitalier Universitaire, Liège, Belgium; Petra Muus and Theo de Witte, Radboudumc, Nijmegen; and Roel Willemze, University Medical Center, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/01/21/JCO.2015.64
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.64.0060
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.64.0060DOI Listing
March 2016

Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?

Haematologica 2016 Mar;101(3):263-5

Division of Experimental Oncology and Department of Onco-Hematology, Università Vita-Salute San Raffaele and IRCCS Instituto Scientifico San Raffaele, Milan, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.139246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815716PMC
March 2016

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.

N Engl J Med 2015 Dec 6;373(25):2425-37. Epub 2015 Dec 6.

From the University of Texas MD Anderson Cancer Center, Houston (J.A.B.); Azienda Ospedaliera Niguarda Cà Granda (A.T.) and Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele (P.G.), Milan, and the Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara (G.G.) - all in Italy; Wilmot Cancer Institute, University of Rochester, Rochester, NY (P.M.B.); Medical University of Lodz and Copernicus Memorial Hospital, Lodz (T.R.), the Department of Cancer Prevention, School of Public Health, Medical University of Silesia, Katowice (S.G.), and the Department of Hematology, University Clinical Center of Medical University of Gdansk, Gdansk (A.H.) - all in Poland; Tom Baker Cancer Centre, Calgary, AB, Canada (C.O.); Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv (O.B.), and Hadassah University Hospital, Hebrew University Medical School, Jerusalem (A.P.) - both in Israel; Leeds Teaching Hospitals, St. James Institute of Oncology, Leeds (P.H.), Kings College Hospital, London (S.D.), Royal Bournemouth Hospital, Bournemouth (H.M.), and University of Oxford, Oxford (A.S.) - all in the United Kingdom; Washington University School of Medicine, St. Louis (N.L.B.); Jiangsu Province Hospital, Nanjing, China (J.L.); North Shore Hospital, Auckland, New Zealand (D. Simpson); Stanford University School of Medicine, Stanford (S.C.), City of Hope National Medical Center, Duarte (T.S.), Pharmacyclics, Sunnyvale (D. Suri, M.C., F.C., L.S., D.F.J.), and Moores Cancer Center, University of California, San Diego, San Diego (T.J.K.) - all in California; St. Vincent's Hospital, University of Melbourne (H.Q.), and Peter MacCallum Cancer Centre and St. Vincent's Hospital (C.S.T.), Melbourne, VIC, Australia; Institute of Blood Pathology and Transfusion Medicine, National Academy of Medical Sciences of Ukraine, Lviv, Ukraine (Z.M.); Norton Cancer Institute, Louisville, KY (D.A.S.);

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1509388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722809PMC
December 2015

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.

J Clin Oncol 2015 Oct 17;33(30):3467-74. Epub 2015 Aug 17.

Laurie H. Sehn, Centre for Lymphoid Cancer, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia; Tara Baetz, Queen's University, Kingston General Hospital, Kingston; Rena Buckstein, Sunnybrook Health Sciences Center; Michael Crump, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Andre Goy and Luis E. Fayad, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ; Fritz C. Offner, Institute of Hematology and Medical Oncology, University of Bologna; Pier Luigi Zinzani, Institute of Hematology "Seràgnoli" University of Bologna, Bologna; Giovanni Martinelli, European Institute of Oncology, Milano; Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; M. Dolores Caballero, University Hospital of Salamanca, Salamanca, Spain; Ole Gadeberg, Vejle Hospital, Vejle, Denmark; Andrew D. Zelenetz, Memorial Sloan Kettering Cancer Center, New York; Jonathan Friedberg, James P. Wilmot Cancer Center, University of Rochester, Rochester, NY; Branimir Jadkisic, Clinical Hospital Merkur, University of Zagreb, Zagreb, Croatia; Swaminathan Padmanabhan Iyer, Houston Methodist Cancer Center, Weill Cornell Medical College, Houston, TX; Deniz Sahin and Günter Fingerle-Rowson, Roche, Basel, Switzerland; Akiko Chai, Genentech BioOncology, South San Francisco, CA; Oliver Press, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.2139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087315PMC
October 2015